Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?-Reference-Cited by-同舟云学术

Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?

Published:2017-10-08 Issue:11 Volume:5 Page:875-887
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Martino Massimo¹^ORCID,Recchia Anna Grazia²,Console Giuseppe¹,Gentile Massimo³,Cimminiello Michele⁴,Gallo Giuseppe Alberto¹,Ferreri Anna¹,Naso Virginia¹,Irrera Giuseppe¹,Messina Giuseppe¹,Moscato Tiziana¹,Vigna Ernesto³,Vincelli Iolanda Donatella⁵,Morabito Fortunato²

Affiliation:

1. Stem Cell Transplant Unit, Department of Onco-Hematology and Radiotherapy, Great Metropolitan Hospital BMM, Reggio Calabria, Italy

2. Unità di Ricerca Biotecnologica (URB), Aprigliano ASP, Cosenza, Italy

3. Hematology Unit, Department of Hemato-Oncology, Ospedale Annunziata, Cosenza, Italy

4. Hematology and Stem Cell Transplantation Unit, “S. Carlo” Hospital, Potenza, Italy

5. Hematology, Department of Onco-Hematology and Radiotherapy, Great Metropolitan Hospital BMM, Reggio, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2017.1387050

Reference100 articles.

1. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

2. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

3. Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience

4. Proteasome inhibitors in multiple myeloma: 10 years later

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melphalan-loaded methoxy poly(ethylene glycol)-poly(d,l-lactide) copolymer nanomicelles in the treatment of multiple myeloma;Chinese Chemical Letters;2023-09

2. The Impact of Induction Regimes on Immune Responses in Patients with Multiple Myeloma;Cancers;2021-08-13

3. Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma;Drug Design, Development and Therapy;2021-07